MarketPeel
Insider Trading Intelligence
SS

Samuel R. Saks

PTGX
CHIEF MEDICAL OFFICER · PROTAGONIST THERAPEUTICS, INC · CIK 0001365615
FILING MIX · LIFETIME100%/0%
BUYS
3
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
90,000
AVG SELL PX
TRADE KIND
SHOWING 3 / 3
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Samuel R. Saks. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
PTGX · 90,000 shares · as of Feb 26, 2021
022,50045,00067,50090,0002021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
FLOW · 3 buys / 0 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
12,00014,000Feb 26, 2021Feb 26, 2021
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
90,00090,000Feb 26, 2021Feb 26, 2021
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
85,00085,000Feb 28, 2020Feb 28, 2020
Other insiders · PTGX
Loading peer insiders…
About this filer
CIK 0001365615
ROLE
Chief Medical Officer
PRIMARY
PTGX
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001365615DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback